Sanny Chan, MD, PhD
Basic profileAllergy & Immunology
Sanny Chan is a Rheumatology/Immunology physician. OpenAlex indexes 21 publications with 759 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year202529 payments$746
- AstraZeneca Pharmaceuticals LPProgram year202516 payments$498
- GENZYME CORPORATIONProgram year202514 payments$455
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
91.1%Leukotriene Receptor Antagonist25.9%Montelukast Sodium100%Part D≥48 patientsHistamine-1 Receptor Antagonist24%Azelastine Hcl60%Azelastine-Fluticasone22%Levocetirizine Dihydrochloride18%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
3.3%Corticosteroid3.3%Prednisone100%Part D≥16 patientsBlood & clotting
2%Plasma Kallikrein Inhibitor2%Orladeyo100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rational discovery of a cancer neoepitope harboring the KRAS G12D driver mutation
Science China Life Sciences
2021 - Chronic Urticaria in Children: an Update on Diagnosis and Treatment
Current Allergy and Asthma Reports
2020 - Editorial: Nomenclature - Avoiding Babylonian Speech Confusion in Present Day Immunology
Frontiers in Immunology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”